Sickle Cell Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have sickle cell disease (specifically the SS or SC type), or you are a healthy person with normal hemoglobin (hemoglobin AA) who could join as a comparison volunteer
- Your sickle cell disease was confirmed by a specialist lab test (such as electrophoresis or HPLC)
- You are older than 6 years and younger than 25 years old at the time of joining the trial
- You are currently in a stable, healthy period — meaning you have had no complications in the past month and no blood transfusions in the past three months
- You are already receiving care for sickle cell disease at the sickle cell center at the University Hospital of Guadeloupe in Pointe-à-Pitre
- You (or a parent/guardian if you are a minor) are willing and able to sign a written consent form agreeing to take part
- You are covered by the national social security (health insurance) system
- Healthy volunteers (with normal hemoglobin) may be recruited through posters displayed at the hospital
Who may not be able to join:
- The exclusion criteria listed in this trial appear to mirror the inclusion criteria, which may be an error in the trial documentation — please confirm the specific reasons for exclusion directly with the trial site (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Maryse Etienne-Julan, MD PhD, CHU de la Guadeloupe
Phone: +590590934677
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Lymphocyte subpopulations measured by flow cytometry at steady-state
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.